Last Updated : June 18, 2024
Details
FilesGeneric Name:
Enzalutamide
Project Status:
Active
Therapeutic Area:
Genito-urinary cancer (prostate cancer)
Manufacturer:
N/A
Call for patient/clinician input open:
Brand Name:
N/A
Project Line:
Reimbursement Review
Project Number:
PX0366-000
Call for patient/clinician input closed:
Biosimilar:
No
Submission Type:
Non-sponsored Submission
Fee Schedule:
Pending
Indications:
For the treatment of
patients with non-metastatic castration-sensitive prostate cancer (nmCSPC) with
biochemical recurrence at high risk of metastasis (high-risk BCR)
Submission received | 30-Apr-24 |
---|
Files
Last Updated : June 18, 2024